查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869783

北美、歐洲和亞太地區基因治療細胞培養基市場規模、佔有率和趨勢分析報告：按產品類型、載體類型、最終用戶、地區和細分市場預測（2026-2033 年）

North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Size, Share & Trends Analysis Report By Product (Specialty Media, Serum-free Media), By Vector Type (AAV, LV), By End User, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

北美、歐洲和亞太地區基因治療細胞培養基市場摘要

2025年，北美、歐洲和亞太地區基因治療細胞培養基市場規模估計為4.383億美元，預計2033年將達到15.338億美元。

預計2026年至2033年，北美、歐洲和亞太地區的基因治療細胞培養基市場將以17.08%的複合年成長率成長。推動該市場成長的主要因素包括臨床試驗活動的增加、生物製造能力的提升以及對符合GMP規範、化學成分明確的培養基日益成長的需求。這些地區正在加速採用高性能培養基，以提高載體產量並簡化生產流程。

罕見遺傳疾病治療的進展和強力的監管支持

開發罕見遺傳疾病治療方法的迫切需求是基因治療細胞培養基市場成長要素。雖然在美國，每種罕見疾病影響的人數不足20萬，但全球約有7000種罕見疾病，總合影響超過2500萬美國。許多此類疾病是由單一基因突變引起的，因此特別適合採用基因療法來糾正或替換缺陷基因。與僅能控制症狀的療法不同，基因療法可望提供長期療效，有時甚至根治性疾病。然而，要實現這一目標需要專門的培養基。研究人員和生產者需要無血清、化學成分明確的培養基，以支持脆弱細胞在從早期實驗室工作到臨床前試驗和大規模臨床生產的各個開發階段。標準的通用培養基通常無法滿足需求，因此需要針對敏感細胞和患者來源細胞類型量身定做的解決方案。

同時，監管政策的改善也使該領域更具投資吸引力。許多國家目前提供加速核准、稅收優惠、延長市場獨佔期或直接資助等項目，旨在降低開發針對小眾患者群體治療方法的風險。儘管這些激勵措施因地區而異，但它們都支持一個通用的目標：使罕見疾病治療在經濟上可行，並讓有需要的患者能夠獲得治療。科學研究機會與監管支援的結合，為生物製藥公司和契約製造創造了一個極具吸引力的環境，使他們能夠投入人才和資源，開發擴充性的高性能培養基解決方案。隨著罕見疾病計畫的擴展，對可靠的客製化培養基的需求將持續成長，從而鞏固其在基因和細胞治療未來發展中的核心地位。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 補貼市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素的影響分析
    • 市場限制因素的影響分析
  • 商業環境分析
    • PESTLE分析
    • 波特五力分析

第4章 產品業務分析

  • 產品細分儀表板
  • 北美、歐洲和亞太地區基因治療細胞培養基市場：產品及變異分析
  • 北美、歐洲及亞太地區基因治療細胞培養基市場規模及趨勢分析（依產品分類，2021-2033 年）
  • 專業領域
  • 無血清培養基
  • 古典媒介
  • 其他

第5章 向量商業分析

  • 向量細分儀表板
  • 北美、歐洲和亞太地區基因治療細胞培養基市場：載體類型和變異分析
  • 北美、歐洲及亞太地區基因治療細胞培養基市場規模及趨勢分析（依載體類型分類，2021-2033 年）
  • AAV製作
  • LV 生產
  • 其他向量

第6章：最終用戶業務分析

  • 最終用戶細分儀表板
  • 北美、歐洲和亞太地區基因治療細胞培養基市場的終端用戶和波動性分析
  • 北美、歐洲和亞太地區基因治療細胞培養基市場規模及趨勢分析（按最終用戶分類，2021-2033 年）
  • 製藥和生物技術公司
  • 合約研發生產力組織（CDMO）和合約研究組織（CRO）
  • 研究和學術機構

7. 北美、歐洲和亞太地區基因治療細胞培養基市場：按產品、載體類型和最終用途分類的區域估算和趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 2021-2033年北美基因治療細胞培養基市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲基因治療細胞培養基市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區：北美、歐洲和亞太地區基因治療細胞培養基市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 新加坡
    • 澳洲
    • 泰國
    • 韓國

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場分析，2025年
  • 公司簡介/上市公司
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Merck KGaA
    • Lonza
    • Danaher Corporation（Cytiva）
    • FUJIFILM Holdings Corporation
    • MP Biomedicals
    • Corning Incorporated
    • PAN-Biotech
    • Bio-Techne（R&D Systems, Inc.）
    • InVitria Inc.
    • Florabio AS
    • Revvity
    • Virica
Product Code: GVR-4-68040-762-6

North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Summary

The North America, Europe & Asia Pacific gene therapy cell culture media market size was estimated at USD 438.3 million in 2025 and is expected to reach a value of USD 1,533.8 million by 2033, growing at a CAGR of 17.08% from 2026 to 2033. The gene therapy cell culture media market in North America, Europe, and the Asia Pacific is driven by rising clinical trial activity, expanding biomanufacturing capacity, and the growing need for GMP-compliant, chemically defined media. Together, these regions are accelerating the adoption of high-performance media to boost vector yields and streamline production.

Growth In Rare Genetic Disease Therapies And Strong Regulatory Support

The push to develop therapies for rare genetic disorders has become a major driver in the gene therapy cell culture media market. Although each rare disease affects fewer than 200,000 people in the U.S., there are nearly 7,000 such conditions worldwide, collectively impacting more than 25 million Americans. Many of these disorders stem from single-gene mutations, which makes them especially suitable for gene therapy approaches that correct or replace faulty genes. Unlike treatments that only manage symptoms, gene therapy has the potential to offer long-term, sometimes even curative outcomes. Achieving this, however, depends on specialized culture media. Researchers and manufacturers need serum-free, chemically defined formulations that can nurture fragile cells across every stage of development from early lab work to preclinical studies and full-scale clinical production. Standard, one-size-fits-all media often falls short, creating demand for tailored solutions for sensitive or patient-derived cell types.

At the same time, regulatory policies are making this field more attractive for investment. Many countries now offer programs that fast-track approvals, grant tax breaks, extend market exclusivity, or provide direct funding, all aimed at reducing the risk of working on therapies for small patient populations. While these incentives vary by region, they all support the same idea of making treatments for rare diseases financially viable and available to the patients who need them. This blend of scientific opportunity and regulatory support is evolving the landscape to make it attractive for biopharma companies and contract manufacturers to invest talent and resources into developing scalable and high-performing media solutions. As rare disease programs expand, the need for reliable, customized culture media will only grow, reinforcing its central role in the future of gene and cell therapies.

North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the North America, Europe & Asia Pacific gene therapy cell culture media market on the basis of product, vector type, end user, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Specialty Media
  • Serum-free Media
  • Classical Media
  • Others
  • Vector Type Outlook (Revenue, USD Million, 2021 - 2033)
  • AAV Production
  • LV Production
  • Other Vectors
  • End User Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical and Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs) & CROs
  • Research and Academic Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Vector Type
    • 1.2.3. End User
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Increasing biobanking activities
      • 3.3.1.2. Increasing capacity for viral vector production
      • 3.3.1.3. Growth in rare genetic disease therapies and strong regulatory support
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. Technical and manufacturing challenges
      • 3.3.2.2. Long development timelines
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Product, Movement Analysis
  • 4.3. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Specialty Media
    • 4.4.1. Specialty Media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Serum-free Media
    • 4.5.1. Serum-free media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Classical Media
    • 4.6.1. Classical media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others media market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Vector Type Business Analysis

  • 5.1. Vector Type Segment Dashboard
  • 5.2. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Vector Type, Movement Analysis
  • 5.3. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Size & Trend Analysis, by Vector Type, 2021 to 2033 (USD Million)
  • 5.4. AAV Production
    • 5.4.1. AAV production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. LV Production
    • 5.5.1. LV production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Other Vectors
    • 5.6.1. Other vectors market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End User Business Analysis

  • 6.1. End User Segment Dashboard
  • 6.2. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market End User, Movement Analysis
  • 6.3. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Contract Development & Manufacturing Organizations (CDMOs) & CROs
    • 6.5.1. Contract development & manufacturing organizations (CDMOs) & CROs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Research and academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market: Regional Estimates and Trend Analysis, by Product, Vector Type, & End User

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. U.S. gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Canada gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Mexico gene therapy cell culture media market, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. UK gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Germany gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. France gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Italy gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Spain gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Denmark gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Sweden gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Target Disease Prevalence
      • 7.4.9.3. Competitive Scenario
      • 7.4.9.4. Regulatory Framework
      • 7.4.9.5. Norway gene therapy cell culture media market, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific North America, Europe & Asia Pacific gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Japan gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. China gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. India gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.5. Singapore
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Singapore gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Regulatory Framework
      • 7.5.6.5. Australia gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Regulatory Framework
      • 7.5.7.5. Thailand gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.8. South Korea
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Regulatory Framework
      • 7.5.8.5. South Korea gene therapy cell culture media market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Sartorius AG
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Danaher Corporation (Cytiva)
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. FUJIFILM Holdings Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. MP Biomedicals
      • 8.4.7.1. Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Corning Incorporated
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. PAN-Biotech
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Bio-Techne (R&D Systems, Inc.)
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. InVitria Inc.
      • 8.4.11.1. Overview
      • 8.4.11.2. Product Benchmarking
      • 8.4.11.3. Strategic Initiatives
    • 8.4.12. Florabio AS
      • 8.4.12.1. Overview
      • 8.4.12.2. Product Benchmarking
      • 8.4.12.3. Strategic Initiatives
    • 8.4.13. Revvity
      • 8.4.13.1. Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Strategic Initiatives
    • 8.4.14. Virica
      • 8.4.14.1. Overview
      • 8.4.14.2. Product Benchmarking
      • 8.4.14.3. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 5 North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market, end user, 2021 - 2033 (USD Million)
  • Table 6 North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America Gene Therapy Cell Culture Media Market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 10 North America Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 11 U.S. Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 13 U.S. Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 14 Canada Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 15 Canada Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 16 Canada Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 17 Mexico Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 18 Mexico Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 19 Mexico Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 20 Europe Gene Therapy Cell Culture Media Market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 22 Europe Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 23 Europe Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 24 Germany Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 25 Germany Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 26 Germany Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 27 UK Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 28 UK Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 29 UK Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 30 France Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 31 France Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 32 France Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 33 Italy Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 34 Italy Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 35 Italy Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 36 Spain Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 37 Spain Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 38 Spain Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 39 Denmark Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 40 Denmark Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 41 Denmark Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 42 Norway Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 43 Norway Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 44 Norway Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 45 Sweden Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 46 Sweden Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 47 Sweden Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Gene Therapy Cell Culture Media Market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Gene Therapy Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 52 China Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 53 China Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 54 China Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 55 Japan Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 56 Japan Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 57 Japan Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 58 India Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 59 India Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 60 India Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 61 South Korea Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 62 South Korea Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 63 South Korea Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 64 Australia Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 65 Australia Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 66 Australia Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 67 Thailand Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 68 Thailand Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 69 Thailand Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 North America, Europe & Asia Pacific gene therapy cell culture media market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 North America, Europe & Asia Pacific gene therapy cell culture media market: Product outlook key takeaways
  • Fig. 19 North America, Europe & Asia Pacific gene therapy cell culture media market: Product movement analysis
  • Fig. 20 Specialty Media market, 2021 - 2033 (USD Million)
  • Fig. 21 Serum-free Media market, 2021 - 2033 (USD Million)
  • Fig. 22 Classical Media market, 2021 - 2033 (USD Million)
  • Fig. 23 Others market, 2021 - 2033 (USD Million)
  • Fig. 24 North America, Europe & Asia Pacific gene therapy cell culture media market: Vector type outlook key takeaways
  • Fig. 25 North America, Europe & Asia Pacific gene therapy cell culture media market: Vector type movement analysis
  • Fig. 26 AAV production market, 2021 - 2033 (USD Million)
  • Fig. 27 LV production market, 2021 - 2033 (USD Million)
  • Fig. 28 Other vectors market, 2021 - 2033 (USD Million)
  • Fig. 29 North America, Europe & Asia Pacific gene therapy cell culture media market: End user outlook key takeaways
  • Fig. 30 North America, Europe & Asia Pacific gene therapy cell culture media market: End user movement analysis
  • Fig. 31 Academic and research institutes market, 2021 - 2033 (USD Million)
  • Fig. 32 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 33 Research and Academic Institutes market, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace outlook, 2025 & 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 North America gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 U.S. gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Canada gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Mexico gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Europe gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Germany gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 UK gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 France gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Italy gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Denmark gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Sweden gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Japan gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 China gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 India gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 South Korea gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Thailand gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Market position analysis
  • Fig. 74 Market participant categorization
  • Fig. 75 Strategic framework